期刊
ALZHEIMERS & DEMENTIA
卷 6, 期 5, 页码 394-403出版社
WILEY
DOI: 10.1016/j.jalz.2009.11.003
关键词
Alzheimer's disease; Family history; APOE epsilon 4;; Diffusion tensor imaging; MRI; White matter
资金
- National Institutes of Health [AG021155, MH62015, R01 AG27161]
- Department of Veterans Affairs
Background: Brain alterations in structure and function have been identified in people with risk factors for sporadic type Alzheimer's disease (AD), suggesting that alterations can be detected decades before AD diagnosis. Although the effect of apolipoprotein E (APOE) epsilon 4 on the brain is well-studied, less is known about the effect of family history of AD. We examined the main effects of family history and APOE epsilon 4 on brain integrity, in addition to assessing possible additive effects of these two risk factors. Methods: Diffusion tensor imaging was performed in 136 middle-aged asymptomatic participants stratified on family history and APOE epsilon 4. Mean diffusivity and fractional anisotropy (FA) were entered in factorial analyses to test the effect of AD risk on microstructural brain integrity. We performed a post hoc analysis of the three principal diffusivities (lambda 1, lambda 2, lambda 3) to provide potential additional insight on underlying tissue differences. Results: Parental family history of AD was associated with lower FA in regions of the brain known to be affected by AD, including cingulum, corpus callosum, tapetum, uncinate fasciculus, hippocampus, and adjacent white matter. Contrary to previous reports, there was no main effect of APOE epsilon 4; however, there was an additive effect of family history and APOE epsilon 4 in which family history positive participants who were also APOE epsilon 4 carriers had the lowest FA compared with the other groups. Conclusions: The data indicate that unknown risk factors contained in family history are associated with changes in microstructural brain integrity in areas of the brain known to be affected by AD. Importantly, the results provide further evidence that AD pathology might be detected before cognitive changes, perhaps decades before disease onset. (c) 2010 The Alzheimer's Association. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据